Literature DB >> 26362957

The protective effects of tadalafil on renal damage following ischemia reperfusion injury in rats.

Bulent Erol1, Tugrul Turker2, Adem Tok2, Sibel Bektas3, Gorkem Mungan4, Seyma Ozkanli5, Bugra Karakas2, Husnu Tokgoz2, Bulent Akduman2, Aydin Mungan2.   

Abstract

Ischemia-reperfusion injury can cause renal damage, and phosphodiesterase inhibitors are reported to regulate antioxidant activity. We investigated the prevention of renal damage using tadalafil after renal ischemia reperfusion (I/R) injury in rats. A total of 21 adult male Wistar albino rats were randomly divided into three groups of seven, including Group 1-control, Group 2-I/R, and Group 3-tadalafil + I/R group (I/R-T group) received tadalafil intraperitoneally at 30 minutes before ischemia. Inducible nitric oxide synthase, endothelial nitric oxide synthase, malondialdehyde, and total antioxidant capacity levels were evaluated, and histopathological changes and apoptosis in the groups were examined. Tadalafil decreased malondialdehyde levels in the I/R group and increased the total antioxidant capacity level. Histopathological and immunohistochemical findings revealed that tadalafil decreased renal injury scores and the ratios of injured cells, as measured through apoptotic protease activating factor 1, inducible nitric oxide synthase, and endothelial nitric oxide synthase levels. We suggest that tadalafil has protective effects against I/R-related renal tissue injury.
Copyright © 2015. Published by Elsevier Taiwan.

Entities:  

Keywords:  Ischemia reperfusion; Kidney; Tadalafil

Mesh:

Substances:

Year:  2015        PMID: 26362957     DOI: 10.1016/j.kjms.2015.06.005

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  2 in total

Review 1.  Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review.

Authors:  Georgios Georgiadis; Ioannis-Erineos Zisis; Anca Oana Docea; Konstantinos Tsarouhas; Irene Fragkiadoulaki; Charalampos Mavridis; Markos Karavitakis; Stavros Stratakis; Kostas Stylianou; Christina Tsitsimpikou; Daniela Calina; Nikolaos Sofikitis; Aristidis Tsatsakis; Charalampos Mamoulakis
Journal:  J Clin Med       Date:  2020-04-29       Impact factor: 4.241

2.  The mechanism of attenuation of epithelial-mesenchymal transition by a phosphodiesterase 5 inhibitor via renal klotho expression.

Authors:  Seung T Han; Jae S Kim; Jun Y Lee; Min K Kim; Jin S Yoo; Byoung G Han; Seung O Choi; Jae W Yang
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-11-22       Impact factor: 2.557

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.